Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-18

FDA Approved: FINGOLIMOD — Original Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Fingolimod from XLCare Pharmaceuticals Inc. as an original-application generic for relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

ORIG AP for FINGOLIMOD (FINGOLIMOD)